Gubra A/S
CSE:GUBRA

Watchlist Manager

Gubra A/S

CSE:GUBRA

Watchlist

Dividends

Discount Rate

Price: 478 DKK 2.14%

Market Cap: 7.8B DKK

Have any thoughts about
Gubra A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 478 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

GUBRA Alert

Gubra A/S

478

+10 (+2.14%)

52 Week Range	114 726
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Gubra A/S

What unique competitive advantages
does Gubra A/S hold over its rivals?

What risks and challenges
does Gubra A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Gubra A/S.

What unique competitive advantages
does Gubra A/S hold over its rivals?

What risks and challenges
does Gubra A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Gubra A/S.

Provide P/S
for Gubra A/S.

Provide P/E
for Gubra A/S.

Provide P/OCF
for Gubra A/S.

Provide P/FCFE
for Gubra A/S.

Provide P/B
for Gubra A/S.

Provide EV/S
for Gubra A/S.

Provide EV/GP
for Gubra A/S.

Provide EV/EBITDA
for Gubra A/S.

Provide EV/EBIT
for Gubra A/S.

Provide EV/OCF
for Gubra A/S.

Provide EV/FCFF
for Gubra A/S.

Provide EV/IC
for Gubra A/S.

Show me price targets
for Gubra A/S made by professional analysts.

Compare the intrinsic valuations
of Gubra A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Gubra A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Gubra A/S compared to its peers.

Compare the P/E ratios
of Gubra A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Gubra A/S with its peers.

Analyze the financial leverage
of Gubra A/S compared to its main competitors.

Show all profitability ratios
for Gubra A/S.

Provide ROE
for Gubra A/S.

Provide ROA
for Gubra A/S.

Provide ROIC
for Gubra A/S.

Provide ROCE
for Gubra A/S.

Provide Gross Margin
for Gubra A/S.

Provide Operating Margin
for Gubra A/S.

Provide Net Margin
for Gubra A/S.

Provide FCF Margin
for Gubra A/S.

Show all solvency ratios
for Gubra A/S.

Provide D/E Ratio
for Gubra A/S.

Provide D/A Ratio
for Gubra A/S.

Provide Interest Coverage Ratio
for Gubra A/S.

Provide Altman Z-Score Ratio
for Gubra A/S.

Provide Quick Ratio
for Gubra A/S.

Provide Current Ratio
for Gubra A/S.

Provide Cash Ratio
for Gubra A/S.

What is the historical Revenue growth
over the last 5 years for Gubra A/S?

What is the historical Net Income growth
over the last 5 years for Gubra A/S?

What is the current Free Cash Flow
of Gubra A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Gubra A/S.

P/S
Price to Sales

34.8

Current

Median

4.2

Industry

Higher than median

Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S

34.8

Market Cap

7.8B DKK

Revenue

223.8m DKK

All Countries

Forward Multiples

			Market Cap	P/S
DK	G	Gubra A/S CSE:GUBRA	7.8B DKK	34.8
US	P	PerkinElmer Inc LSE:0KHE	1.3T USD	486
US		Thermo Fisher Scientific Inc NYSE:TMO	207B USD	4.9
US		Danaher Corp NYSE:DHR	174.4B USD	8.2
KR		Samsung Biologics Co Ltd KRX:207940	68.4T KRW	16.2
CH		Lonza Group AG SIX:LONN	40.2B CHF	6
US		IQVIA Holdings Inc NYSE:IQV	38.4B USD	2.5
US		Agilent Technologies Inc NYSE:A	38.6B USD	5.9
US		Mettler-Toledo International Inc NYSE:MTD	27.3B USD	7.3
US		West Pharmaceutical Services Inc NYSE:WST	24.9B USD	8.7
US		Illumina Inc NASDAQ:ILMN	23.3B USD	5.3

				Revenue Growth
DK	G	Gubra A/S CSE:GUBRA	Average P/S: 53.3 34.8	N/A
US	P	PerkinElmer Inc LSE:0KHE	486	16%
US		Thermo Fisher Scientific Inc NYSE:TMO	4.9	14%
US		Danaher Corp NYSE:DHR	8.2	14%
KR		Samsung Biologics Co Ltd KRX:207940	16.2	60%
CH		Lonza Group AG SIX:LONN	6	33%
US		IQVIA Holdings Inc NYSE:IQV	2.5	15%
US		Agilent Technologies Inc NYSE:A	5.9	8%
US		Mettler-Toledo International Inc NYSE:MTD	7.3	12%
US		West Pharmaceutical Services Inc NYSE:WST	8.7	14%
US		Illumina Inc NASDAQ:ILMN	5.3	7%

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/S

N/A

2-Years Forward

P/S

N/A

3-Years Forward

P/S

N/A

Gubra A/S
CSE:GUBRA

P/S
Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Gubra A/S CSE:GUBRA

P/S Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Gubra A/S
CSE:GUBRA

P/S
Price to Sales